rs199740131

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_031844.3(HNRNPU):​c.1460G>C​(p.Gly487Ala) variant causes a missense change. The variant allele was found at a frequency of 0.0000452 in 1,613,398 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.00014 ( 0 hom., cov: 33)
Exomes 𝑓: 0.000036 ( 2 hom. )

Consequence

HNRNPU
NM_031844.3 missense

Scores

1
9
9

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 4.93

Publications

0 publications found
Variant links:
Genes affected
HNRNPU (HGNC:5048): (heterogeneous nuclear ribonucleoprotein U) This gene encodes a member of a family of proteins that bind nucleic acids and function in the formation of ribonucleoprotein complexes in the nucleus with heterogeneous nuclear RNA (hnRNA). The encoded protein has affinity for both RNA and DNA, and binds scaffold-attached region (SAR) DNA. Mutations in this gene have been associated with epileptic encephalopathy, early infantile, 54. A pseudogene of this gene has been identified on chromosome 14. [provided by RefSeq, Jun 2017]
HNRNPU Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • developmental and epileptic encephalopathy, 54
    Inheritance: AD Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.021663368).
BP6
Variant 1-244858045-C-G is Benign according to our data. Variant chr1-244858045-C-G is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 406729.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population eas. GnomAd4 allele frequency = 0.000138 (21/151684) while in subpopulation EAS AF = 0.00213 (11/5162). AF 95% confidence interval is 0.00119. There are 0 homozygotes in GnomAd4. There are 11 alleles in the male GnomAd4 subpopulation. Median coverage is 33. This position passed quality control check.
BS2
High AC in GnomAd4 at 21 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
HNRNPUNM_031844.3 linkc.1460G>C p.Gly487Ala missense_variant Exon 7 of 14 ENST00000640218.2 NP_114032.2 Q00839-1Q96BA7
HNRNPUNM_004501.3 linkc.1403G>C p.Gly468Ala missense_variant Exon 7 of 14 NP_004492.2 Q00839-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
HNRNPUENST00000640218.2 linkc.1460G>C p.Gly487Ala missense_variant Exon 7 of 14 1 NM_031844.3 ENSP00000491215.1 Q00839-1

Frequencies

GnomAD3 genomes
AF:
0.000139
AC:
21
AN:
151596
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.000121
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0000657
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00213
Gnomad SAS
AF:
0.000831
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.0000916
AC:
23
AN:
251114
AF XY:
0.0000810
show subpopulations
Gnomad AFR exome
AF:
0.0000616
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.000761
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.000327
GnomAD4 exome
AF:
0.0000356
AC:
52
AN:
1461714
Hom.:
2
Cov.:
33
AF XY:
0.0000303
AC XY:
22
AN XY:
727162
show subpopulations
African (AFR)
AF:
0.0000598
AC:
2
AN:
33470
American (AMR)
AF:
0.00
AC:
0
AN:
44706
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26128
East Asian (EAS)
AF:
0.000378
AC:
15
AN:
39696
South Asian (SAS)
AF:
0.000209
AC:
18
AN:
86210
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53414
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5766
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1111938
Other (OTH)
AF:
0.000265
AC:
16
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.495
Heterozygous variant carriers
0
3
6
10
13
16
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000138
AC:
21
AN:
151684
Hom.:
0
Cov.:
33
AF XY:
0.000149
AC XY:
11
AN XY:
74064
show subpopulations
African (AFR)
AF:
0.000121
AC:
5
AN:
41380
American (AMR)
AF:
0.0000656
AC:
1
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00213
AC:
11
AN:
5162
South Asian (SAS)
AF:
0.000832
AC:
4
AN:
4806
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10378
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
67940
Other (OTH)
AF:
0.00
AC:
0
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.523
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0000113
Hom.:
0
Bravo
AF:
0.0000831
ESP6500AA
AF:
0.000227
AC:
1
ESP6500EA
AF:
0.00
AC:
0
ExAC
AF:
0.000107
AC:
13
Asia WGS
AF:
0.00491
AC:
17
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Apr 01, 2023
CeGaT Center for Human Genetics Tuebingen
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

HNRNPU: PP2, BS1 -

Mar 13, 2020
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 54 Benign:1
Jan 17, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Inborn genetic diseases Benign:1
Jun 28, 2019
Ambry Genetics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.52
BayesDel_addAF
Benign
-0.12
T
BayesDel_noAF
Uncertain
-0.040
CADD
Pathogenic
27
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.60
.;D;.;.;.;.;.;.;.
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.51
FATHMM_MKL
Uncertain
0.96
D
LIST_S2
Uncertain
0.90
D;D;D;D;D;D;D;D;D
M_CAP
Benign
0.016
T
MetaRNN
Benign
0.022
T;T;T;T;T;T;T;T;T
MetaSVM
Benign
-0.70
T
MutationAssessor
Benign
1.6
.;L;.;.;.;.;.;.;.
PhyloP100
4.9
PrimateAI
Uncertain
0.77
T
PROVEAN
Pathogenic
-4.5
D;.;.;.;.;.;.;.;.
REVEL
Benign
0.20
Sift
Benign
0.15
T;.;.;.;.;.;.;.;.
Sift4G
Benign
0.095
T;.;.;.;.;.;.;.;.
Polyphen
0.92
P;D;.;.;.;.;.;.;.
Vest4
0.64
MVP
0.77
MPC
0.67
ClinPred
0.079
T
GERP RS
5.8
PromoterAI
0.0092
Neutral
RBP_binding_hub_radar
0.92
RBP_regulation_power_radar
2.6
Varity_R
0.47
gMVP
0.89
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199740131; hg19: chr1-245021347; API